Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System
30 Novembre 2023 - 2:30PM
Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the
“Company”), a medical technology company delivering intelligent,
rapid, non-invasive testing solutions, today announced that Titan
Cranes and Rigging Pty Ltd. ("Titan") has adopted the Company's
unique Intelligent Fingerprinting Drug Screening System.
Since 2001, Titan has secured its spot as
Australasia’s leading specialist material handling company,
providing state-of-the-art lifting equipment and labor to the
country’s largest construction projects. Australia’s construction
industry is a key economic driver and employer for approximately
9.6% of workers1. The industry generates over $360 billion in
annual revenue, producing about 9% of Australia’s gross domestic
profit2. Titan has adopted INBS’ system across its operations as a
new screening solution for its 350-plus employees.
The Intelligent Fingerprinting Drug Screening
System is a fast and accurate testing solution that utilizes
fingerprint sweat to screen for specific drugs of abuse and provide
results within minutes. A small tamper-proof cartridge collects the
sweat samples, which are then analyzed by a reader to determine if
an employee is fit for duty. The Company’s comprehensive solution
also includes a lab-based confirmation service for non-negative
on-site test results.
Harry Simeonidis, President and Chief Executive
Officer at Intelligent Bio Solutions, said, “Our drug screening
product’s reputation is growing globally as a sound and reliable
screening solution. We’re pleased to see our system being
implemented by Titan as a non-invasive, clean, fast screening test,
providing quick on-site results and supporting operational
efficiency. We’re motivated to expand our reach further within the
construction industry and assist more companies with mitigating
drug use and potential impairment at work.”
An introductory video demonstrating the
Intelligent Fingerprinting Drug Screening System is available
here.
About Intelligent Bio
Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is
a medical technology company delivering innovative, rapid,
non-invasive testing solutions. The Company believes that its
Intelligent Fingerprinting Drug Screening System will revolutionize
portable testing through fingerprint sweat analysis, which has the
potential for broader applications in additional fields. Designed
as a hygienic and cost-effective system, the test screens for
recent use of drugs commonly found in the workplace, including
opiates, cocaine, methamphetamine, and cannabis. With sample
collection in seconds and results in under ten minutes, this
technology would be a valuable tool for employers in
safety-critical industries. Additionally, the Company's biosensor
platform has the potential to test for up to 130 indications,
ranging from glucose to immunological conditions and communicable
diseases. The Company's current customer segments include
construction, manufacturing and engineering, transport and
logistics firms, drug treatment organizations, and coroners.
For more information, visit:
https://ibs.inc/
About Titan Cranes and
Rigging Pty Ltd.
Titan Cranes and Rigging Pty Ltd is a privately
owned and operated Australian company. Established in 2001, the
company has become a market leader for specialist material handling
within the Australasian region. The core business for Titan Cranes
and Rigging Pty Ltd is to provide specialist lifting equipment and
personnel to construction projects. Its primary service is the
delivery of tower cranes & hoists over a wide range of
industries including government, residential, infrastructure,
mining and commercial sectors. Titan is guided by its company
vision, which is to always strive for business integrity, quality
of service, a safe workplace, relationships management and
commitment to each and every project.
For more information, visit:
https://titancranes.com.au/
Forward-Looking Statements:
Some of the statements in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act
of 1934, and the Private Securities Litigation Reform Act of 1995,
which involve risks and uncertainties. Forward-looking statements
in this press release include, without limitation, Intelligent Bio
Solutions Inc.'s ability to successfully develop and commercialize
its drug and diagnostic tests, realize commercial benefit from its
partnerships and collaborations, and secure regulatory approvals.
Although Intelligent Bio Solutions Inc. believes that the
expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Intelligent Bio Solutions Inc. has
attempted to identify forward-looking statements by terminology,
including “believes,"" estimates,"" anticipates,"" expects,""
plans,"" projects,"" intends,"" potential,"" may,"" could,""
might,"" will,"" should,"" approximately" or other words that
convey uncertainty of future events or outcomes to identify these
forward-looking statements. These statements are only predictions
and involve known and unknown risks, uncertainties, and other
factors, included in Intelligent Bio Solutions' public filings
filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this release speak only as
of its date. Intelligent Bio Solutions undertakes no obligation to
update any forward-looking statements contained in this release to
reflect events or circumstances occurring after its date or to
reflect the occurrence of unanticipated events.
Company Contact:
Intelligent Bio Solutions Inc.New York Office:
#646-790-5756info@ibs.incLinkedIn | Twitter
Investor Relations:Valter
Pinto, Managing DirectorKCSA Strategic Communications#(212)
896-1254INBS@kcsa.com
Media Contact: Cheryl Billson
Comma Communications cheryl.billson@commacomms.com
1
https://labourmarketinsights.gov.au/industries/industry-details?industryCode=E2
https://www.mordorintelligence.com/industry-reports/australia-construction-market
Grafico Azioni Intelligent Bio Solutions (NASDAQ:INBS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Intelligent Bio Solutions (NASDAQ:INBS)
Storico
Da Giu 2023 a Giu 2024